Back to Candriam S.C.A.

ALNY
Showing 8 of 29 quarters

Position history for Candriam S.C.A.'s holdings in ALNYLAM PHARMACEUTICALS INC

Candriam S.C.A. holds 224,330 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $74.2M as of 2026-Q1. ALNY represents 0.4% of Candriam S.C.A.'s portfolio.

Current Value

$74.2M

Current Shares

224,330

Total Value Change

-$11.1M

Total Shares Change

-126,898

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
224,330
0.0%
$74.2M0.4%$318.65
0
2025-Q4
Increased
224,330
+5.6%
$89.2M0.4%$397.25
38
2025-Q3
Decreased
212,416
-10.8%
$96.9M0.5%$447.49
0
2025-Q2
Decreased
238,084
-4.7%
$77.6M0.4%$322.83
0
2025-Q1
Decreased
249,919
-11.5%
$67.5M0.4%$268.46
0
2024-Q4
Decreased
282,407
-19.7%
$66.5M0.4%$236.01
0
2024-Q3
Increased
351,668
+0.1%
$96.7M0.6%$274.91
42
2024-Q2
Increased
351,228
+10.8%
$85.3M0.5%$243.00
47

Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used